Treatment of pulmonary exacerbations in cystic fibrosis - could do better?

被引：4
|
作者：
Smyth, Alan [1 ]
机构：
[1] Univ Nottingham, Sch Med, Nottingham NG7 2RD, England
来源：
PAEDIATRIC RESPIRATORY REVIEWS | 2016年 / 20卷
关键词：
Cystic fibrosis; Pulmonary exacerbations; Symptom score; Microbiome; Adverse effects of antibiotics; ACUTE-RENAL-FAILURE; TOBRAMYCIN; UK;
D O I：
10.1016/j.prrv.2016.06.004
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
This article describes the nature and significance of pulmonary exacerbations in cystic fibrosis (CF). The effectiveness and safety of current exacerbation treatment are explored. The article concludes with a summary of clinical trials (completed and ongoing) which aim to improve the efficacy and safety of exacerbation treatment. (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码：6 / 7
页数：2
相关论文
共 50 条
  • [41] Home intravenous antibiotic treatment for acute pulmonary exacerbations in cystic fibrosis - Is it good for the patient?
    Sequeiros, Iara Maria
    Jarad, Nabil A.
    ANNALS OF THORACIC MEDICINE, 2009, 4 (03) : 111 - 114
  • [42] Ceftaroline vs vancomycin for the treatment of acute pulmonary exacerbations in pediatric patients with cystic fibrosis
    Branstetter, Joshua
    Searcy, Heather
    Benner, Kim
    Yarbrough, April
    Crowder, Carly
    Troxler, Brad
    PEDIATRIC PULMONOLOGY, 2020, 55 (12) : 3337 - 3342
  • [43] Twice vs three times daily antibiotics in the treatment of pulmonary exacerbations of cystic fibrosis
    Smyth, Alan
    Knox, Alan
    JOURNAL OF CYSTIC FIBROSIS, 2011, 10 (05) : 383 - 383
  • [44] State of the art in cystic fibrosis pharmacology optimization of antimicrobials in the treatment of cystic fibrosis pulmonary exacerbations: III. Executive summary
    Epps, Quovadis J.
    Epps, Kevin L.
    Young, David C.
    Zobell, Jeffery T.
    PEDIATRIC PULMONOLOGY, 2021, 56 (07) : 1825 - 1837
  • [45] Comparative Effectiveness of Vancomycin Versus Linezolid for the Treatment of Acute Pulmonary Exacerbations of Cystic Fibrosis
    Fusco, Nicholas M.
    Meaney, Calvin J.
    Frederick, Carla A.
    Prescott, William A., Jr.
    ANNALS OF PHARMACOTHERAPY, 2020, 54 (03) : 197 - 204
  • [46] Therapeutic drug monitoring in cystic fibrosis and associations with pulmonary exacerbations and lung function
    Katz, Jason Brandon
    Shah, Purav
    Trillo, Cesar A.
    Alshaer, Mohammad H.
    Peloquin, Charles
    Lascano, Jorge
    RESPIRATORY MEDICINE, 2023, 212
  • [47] Pulmonary Exacerbations in Pediatric Patients: Retrospective Study in a Portuguese Cystic Fibrosis Center
    Cardoso, Rosa
    Cardoso, Ana Lucia
    Barbosa, Telma
    CHILDREN-BASEL, 2022, 9 (02):
  • [48] Oral, inhaled, and intravenous antibiotic choice for treating pulmonary exacerbations in cystic fibrosis
    Wagener, Jeffrey S.
    Rasouliyan, Lawrence
    VanDevanter, Donald R.
    Pasta, David J.
    Regelmann, Warren E.
    Morgan, Wayne J.
    Konstan, Michael W.
    PEDIATRIC PULMONOLOGY, 2013, 48 (07) : 666 - 673
  • [49] Effect of esomeprazole versus placebo on pulmonary exacerbations in cystic fibrosis
    Emily DiMango
    Patricia Walker
    Claire Keating
    Maria Berdella
    Newell Robinson
    Elinor Langfelder-Schwind
    Diane Levy
    Xinhua Liu
    BMC Pulmonary Medicine, 14
  • [50] BEAT CF pulmonary exacerbations core protocol for evaluating the management of pulmonary exacerbations in people with cystic fibrosis
    Andre Schultz
    Charlie McLeod
    Scott Berry
    Julie Marsh
    Anne McKenzie
    Mitch Messer
    Jamie Wood
    Ben Saville
    Adam Jaffe
    Sarath Ranganathan
    Steve Stick
    Peter Wark
    Steve Webb
    Tom Snelling
    Trials, 24
12345